Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · IEX Real-Time Price · USD
7.91
-0.35 (-4.24%)
At close: Jul 2, 2024, 4:00 PM
7.70
-0.21 (-2.65%)
After-hours: Jul 2, 2024, 7:02 PM EDT
Delcath Systems Market Cap
Delcath Systems has a market cap or net worth of $219.79 million as of July 2, 2024. Its market cap has increased by 268.77% in one year.
Market Cap
219.79M
Enterprise Value
201.09M
1-Year Change
268.77%
Ranking
Category
Stock Price
$7.91
Market Cap Chart
Since May 10, 2018, Delcath Systems's market cap has increased from $2.70M to $219.79M, an increase of 8,040.21%. That is a compound annual growth rate of 104.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 219.80M | 139.69% |
| Dec 29, 2023 | 91.70M | 195.81% |
| Dec 30, 2022 | 31.00M | -45.61% |
| Dec 31, 2021 | 57.00M | -22.76% |
| Dec 31, 2020 | 73.80M | 9,125.00% |
| Dec 31, 2019 | 800.00K | -68.00% |
| Dec 31, 2018 | 2.50M | -7.41% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AngioDynamics | 226.71M |
| Greenwich LifeSciences | 226.69M |
| CorMedix | 226.43M |
| Cibus | 225.90M |
| Omeros | 223.37M |
| Monte Rosa Therapeutics | 220.14M |
| Aquestive Therapeutics | 219.86M |
| Inovio Pharmaceuticals | 218.95M |